AQP9 Membrane Protein Introduction

Introduction of AQP9

AQP9, encoded by the AQP9 gene, is an aquaglyceroporin membrane channel shown biophysically to conduct water, glycerol, and other small solutes. Sharing greater sequence identity with AQP3, AQP7 and AQP10, AQP9 is predicted to comprise 295 amino acids, containing 6 transmembrane regions and an intracellular N- and C-termini. AQP9 is widely expressed in different tissues with high levels in peripheral leukocytes, and lower levels in liver, lung, and spleen. AQP9 gene is mapped to chromosome 15.

Basic Information of AQP9
Protein Name Aquaporin-9
Gene Name AQP9
Aliases Aquaglyceroporin-9, Small solute channel 1
Organism Homo sapiens (Human)
UniProt ID O43315
Transmembrane Times 5
Length (aa) 295

Function of AQP9 Membrane Protein

As a member of the aquaglyceroporin subfamily of aquaporins, AQP9 can transport not only water, but also small uncharged molecules like glycerol, monocarboxylates, urea, purines, and pyrimidines. In addition, AQP9 has been proposed to transport a variety of neutral and ionic arsenic species, including arsenic trioxide, monomethyl arsenate (MAsIII) and dimethyl arsenate (DMAV). AQP9 expression has also been shown to be regulated by testosterone and estrogen. The expression of AQP9 in the male reproductive tract has been shown to be involved in sperm maturation, concentration, and storage, respectively. Moreover, AQP9 expression in the liver is down-regulated by insulin, potentially via an “insulin-responsive element” in the AQP9 promoter. In the patients with astrocytoma, it is documented that AQP9 can promote the invasion and motility of cells via the AKT pathway, indicating that AQP9 may represent a potential target for therapeutic use of astrocytoma. AQP9 blockade can be an effective strategy to reduce dendritic cells (DCs) inflammatory response. However, it is not sufficient to protect from acute inflammatory insults such as dextra sulfate sodium (DSS) induced colitis.

The role of AQP9 in islet secreting cells. Fig.1 The role of AQP9 in islet secreting cells. (Lebeck, 2014)

Application of AQP9 Membrane Protein in Literature

  1. Takeuchi K., et al. Downregulation of aquaporin 9 decreases catabolic factor expression through nuclear factor kappaB signaling ins chondrocytes. Int J Mol Med. 2018, 42(3):1548-1558. PubMed ID: 29901079

    This article reveals that AQP9 is highly expressed in OA cartilage and the downregulation of AQP9 in cultured chondrocytes can decrease the catabolic gene expression in response to IL-1β stimulation via NF-κB signaling, suggesting AQP9 may be a promising target for the treatment of OA.

  2. Stahl K., et al. Targeted deletion of the aquaglyceroporin AQP9 is protective in a mouse model of Parkinson's disease. PLoS One. 2018, 13: e0194896. PubMed ID: 29566083

    These results show that AQP9 can selectively be expressed in catecholaminergic neurons, where it is permeable to MPP+, indicating that AQP9 contributes to the selective vulnerability of nigral dopaminergic neurons by providing an entry route for parkinsonogenic toxins.

  3. Hou J., et al. Similar Aquaporin9 and MAPK Expression Profiles in the Liver of Types 1 and 2 Diabetes Mellitus. Horm Metab Res. 2018, 50: 414-421. PubMed ID: 29523003

    This study examines the expression patterns of AQP9 and mitogen-activated protein kinase (MAPK) in Types 1 and 2 diabetes mellitus (DM). And they clarify the roles and regulating mechanism of AQP9 in gluconeogenesis.

  4. Han X., et al. Changes in the Expression of AQP4 and AQP9 in the Hippocampus Following Eclampsia-Like Seizure. Int J Mol Sci. 2018, 19(1). PubMed ID: 29351212

    These findings show that upregulation of AQP4 and AQP9 may be responsible for the cell death induced by eclamptic seizures.

  5. Vilarino-Garcia T., et al. Leptin upregulates aquaporin 9 expression in human placenta in vitro. Gynecol Endocrinol 2018, 34: 175-177. PubMed ID: 28942694

    This article demonstrates that leptin can produce a dose-dependent increase of AQP9 gene expression, resulting in an increase in AQP9 protein in human trophoblast explants.

AQP9 Preparation Options

To obtain the soluble and functional target protein, we have developed advanced Magic™ membrane protein production platform, and aided by which, we are able to present target membrane protein in multiple active formats. Our professional scientists are pleased to help you find a better match for your particular project to make get milestone success. Aided by our versatile Magic™ anti-membrane protein antibody discovery platform, we also provide customized anti-AQP9 antibody development services.

As a forward-looking research institute as well as a leading custom service provider in the field of membrane protein, Creative Biolabs provides high-quality membrane protein preparation service to facilitate the development of worldwide customer’s research. During the past years, we have successfully established a powerful Magic™ membrane protein platform which enables us to provide a series of membrane protein preparation services. For more detailed information, please feel free to contact us.


  1. Lebeck J. (2014). Metabolic impact of the glycerol channels AQP7 and AQP9 in adipose tissue and liver. Journal of molecular endocrinology. JME-13-0268.

Online Inquiry

Verification code
Click image to refresh the verification code.


USA: 45-1 Ramsey Road, Shirley, NY 11967, USA
Europe: Heidenkampsweg 58, 20097 Hamburg, Germany
Call us at:
USA: 1-631-381-2994
Europe: 44-207-097-1828
Fax: 1-631-207-8356
Our customer service representatives are available 24 hours a day, 7 days a week. Contact Us